Dechra increases its 2018 full year dividend by 18.9%

DividendMax Ltd.

Dechra increases its 2018 full year dividend by 18.9%

Dechra Pharmaceuticals 2018 final results

Strong financial performance:

Revenue growth of 13.9% to £407.1 million.

Underlying operating profit growth of 24.0% to £99.2 million.

Underlying EBIT margin expansion of 200 bps to 24.4%.

Underlying diluted EPS increased by 20.9% to 76.45 pence.

Full year dividend of 25.50 pence, up 18.9%.

Companies mentioned